Ginkgo Bioworks Holdings (DNA) EBITDA Margin Growth (5y) (2025 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) EBITDA Margin Growth (5y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.57 Bn | 40.49 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.45 Bn | 15.94 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 4 | Icon | 12.56 Bn | 11.63 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.59 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 625.08 Mn | 199.20 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 420.38 Mn | 335.84 Mn | 18.44 Mn |
| 8 | Champions Oncology | 70.27 Mn | 70.27 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.92 Mn | 51.64 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,310.00 |
| Mar 31, 2026 | -23,699.00 |
| Dec 31, 2025 | -3,752.00 |
| Sep 30, 2025 | 2,692.00 |